Details for New Drug Application (NDA): 201887
✉ Email this page to a colleague
The generic ingredient in ENSKYCE is desogestrel; ethinyl estradiol. There are eight drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the desogestrel; ethinyl estradiol profile page.
Summary for 201887
| Tradename: | ENSKYCE |
| Applicant: | Lupin Ltd |
| Ingredient: | desogestrel; ethinyl estradiol |
| Patents: | 0 |
Suppliers and Packaging for NDA: 201887
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ENSKYCE | desogestrel; ethinyl estradiol | TABLET;ORAL-28 | 201887 | ANDA | Lupin Pharmaceuticals, Inc. | 68180-739 | 68180-739-73 | 3 POUCH in 1 CARTON (68180-739-73) / 1 BLISTER PACK in 1 POUCH / 1 KIT in 1 BLISTER PACK * 21 TABLET, FILM COATED in 1 BLISTER PACK (68180-787-74) * 7 TABLET in 1 BLISTER PACK (68180-794-74) |
| ENSKYCE | desogestrel; ethinyl estradiol | TABLET;ORAL-28 | 201887 | ANDA | Lupin Pharmaceuticals, Inc. | 68180-891 | 68180-891-73 | 3 POUCH in 1 CARTON (68180-891-73) / 1 BLISTER PACK in 1 POUCH / 1 KIT in 1 BLISTER PACK |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL-28 | Strength | 0.15MG;0.03MG | ||||
| Approval Date: | Mar 7, 2013 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
